Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit

Clinical Neurology and Neurosurgery

Volumn 109, Issue 7, 2007, Pages 567-570

  Yoneda, Yukihiro ^a   Yamamoto, Shinji ^a   Hara, Yoshie ^a   Ohta, Kohei ^a   Matsushita, Makoto ^a   Yamamoto, Daisuke ^a   Yamashita, Haruo ^a   Hosoda, Kohkichi ^b  

^a Kobe Red Cross Hospital   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Asia; Japan; Stroke; Thrombolysis; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DISEASE SEVERITY; DRUG SAFETY; FEMALE; HUMAN; IMAGE ANALYSIS; INFARCTION; JAPAN; LICENSING; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; RANKIN SCALE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CEREBRAL INFARCTION; DISABILITY EVALUATION; DRUG APPROVAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; INTRACRANIAL HEMORRHAGES; JAPAN; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 34347402604     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2007.05.002     Document Type: Article

References (14)

1. Yamaguchi T., Mori E., Minematsu K., Nakagawara J., Hashi K., et al., for the Japan Alteplase Clinical Trial (J-ACT) Group. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 h of onset. Stroke 37 (2006) 1810-1815
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
3. European Stroke Initiative. Recommendations for stroke management-update 2003. Cerebrovasc Dis 2003;16:311-37.
4. Hacke W., Donnan G., Fieschi C., Kaste M., von Kummer R., Broderick J.P., et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363 (2004) 768-774
5. Albers G.W., Bates V.E., Clark W.M., Bell R., Verro P., and Hamilton S.A. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283 (2000) 1145-1150
6. Wahlgren N., Ahmed N., Davalos A., Ford G.A., Grond M., Hacke W., et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369 (2007) 275-282
7. Demchuk A.M., Tanne D., Hill M.D., Kasner S.E., Hanson S., Grond M., et al. Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology 57 (2001) 474-480
8. Molina C.A., Montaner J., Abilleira S., Arenillas J.F., Ribo M., Huertas R., et al. Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case-control study. Stroke 32 (2001) 2821-2827
9. Linfante I., Llinas R.H., Selim M., Chaves C., Kumar S., Parker R.A., et al. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 33 (2002) 2066-2071
10. Lindsberg P.J., Soinne L., Tatlisumak T., Roine R.O., Kallela M., Happola O., et al. Long-term outcome after intravenous thrombolysis of basilar artery occlusion. JAMA 292 (2004) 1862-1866
11. Lee K., Han S.W., Kim S.H., Nam H.S., Ahn S.W., Kim D.J., et al. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients. Stroke 38 (2007) 192-193
12. Suwanwela N.C., Phanthumchinda K., and Likitjaroen Y. Thrombolytic therapy in acute ischemic stroke in Asia: the first prospective evaluation. Clin Neurol Neurosurg 108 (2006) 549-552
13. Chiu D., Krieger D., Villar-Cordova C., Kasner S.E., Morgenstern L.B., Bratina P.L., et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 29 (1998) 18-22
14. Grond M., Stenzel C., Schmülling S., Rudolf J., Neveling M., Lechleuthner A., et al. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 29 (1998) 1544-1549